我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

原发性局灶节段性肾小球硬化患者中医证型分布 与临床、病理关系及预后分析*(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2018年05期
页码:
32-37
栏目:
临床研究
出版日期:
2019-06-24

文章信息/Info

Title:
Correlation among Syndrome of TCM, Clinical Manifestations, Pathological Symptoms and Prognosis of Primary Focal Segmental Glomerulosclerosis
文章编号:
1000-2723(2018)05-0032-06
作者:
李先法孙 玥朱彩凤朱 斌倪 军杜园园俞东容胡云琴陈洪宇
(杭州市中医院,浙江 杭州 310000)
Author(s):
LI Xianfa SUN Yue ZHU Caifeng ZHU Bin NI Jun DU yuanyuan YU Dongrong HU Yunqin CHEN Hongyu
(Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou310007, China)
关键词:
局灶节段性肾小球硬化 原发性肾小球肾炎 中医证型
Keywords:
focal segmental glomerulosclerosis primary glomerulonephritis syndrome of TCM
分类号:
R259
DOI:
10.19288/j.cnki.issn.1000-2723.2018.05.007
文献标识码:
A
摘要:
目的 探讨原发性局灶节段性肾小球硬化(pFSGS)患者中医证型与临床病理及预后相关性。方法 选取1996年至2012年期间住院行肾活检连续确诊的pFSGS患者,收集患者中医证候、临床病理资料,并进行随访,探讨其相关性。结果 (1)纳入102例pFSGS,均有脉络瘀阻证,占100%,无单一证型者;二联证有66例,占64.7%,其中气阴两虚、脉络瘀阻(气阴二联证)24例,占23.5%,风湿内扰、脉络瘀阻(风湿二联证)42例,占41.2%;气阴两虚、脉络瘀阻、风湿内扰(三联证)36例,占35.3%。(2)风湿二联证及三联证二者尿蛋白定量、NS患者比例、尿NAG/Cr、血总胆固醇、HDL、LDL均较气阴二联证高(P<0.05),血清白蛋白、IgG水平较气阴二联证低(P<0.05)。(3)IgM免疫沉积率以风湿二联证最高,达76.3%,较气阴二联证差异有统计学意义(P<0.05)。(4)纳入pFSGS患者以非特异病理亚型为主,3组证型分布差异无统计学意义(P>0.05),塌陷型2例分别具风湿二联证和三联证,尖端型4例均具风湿二联证,门部型平均分布于3组证型中。(5)随访患者中新进展至终点事件有5例,分别具风湿二联证2例和三联证3例,但生存分析3组无差异(P>0.05)。结论 PFSGS患者以二联证为主要证型,其中以风湿二联证及三联证临床表现较重,预后相对较差。
Abstract:
Objective To analyze the relationship among TCM Syndrome, clinical pathology and prognosis of pFSGS. Methods One hundred and two patients with pFSGS in the Department of Nephrology between 1996 and 2012 were retrospectively studied. We analyzed the relationship among TCM Syndrome, clinical pathology and prognosis of pFSGS. Results 1) All the 102 pFSGS patients have mailuoyuzu syndrome, without single syndrome. Among them, 66 patients have bigeminy syndrome, accounting for 64.7%, wherein qiyinliangxu, mailuoyuzu syndrome(qiyin-united syndrome) accounting for 23.5%, fengshineirao, mailuoyuzu syndrome(fengshi-united syndrome) accounting for 41.2%. 36 patients have sheqiyinliangxu, mailuoyuzu, fengshineirao(triad syndrome), accounting for 35.3%. 2) Fengshi-united syndrome and triad syndrome are both higher in urinary protein, the proportion of NS patients, urinary NAG/Cr, serum total cholesterol, HDL, LDL, than that in qiyin-united syndrome(P<0.05). But they are lower in serum albumin, IgG levels than that in qiyin-united syndrome(P<0.05). 3) The IgM immune deposition rate in fengshi-united syndrome is 76.3%, higher than qiyin-united syndrome(P<0.05). 4) Collapsing variant have two cases, each of them has fengshi-united syndrome and triad syndrome. The tip FSGS has 4 cases with fengshi-united syndrome. 5) Five cases in the follow-up patients with normal baseline serum creatinine progressed to endpoint events, among them have fengshi-united syndrome in two cases and triad syndrome in three cases. However, the survival rates of these three groups syndrome are not significant difference(P>0.05). Conclusion PFSGS patients all have mailuoyuzu syndrome, without single syndrome. The qiyin-united and fengshi-united syndromes are the main syndrome types. Fengshi-united syndrome and triad syndrome groups have serious clinical manifestation, and maybe have a worse outcome.

参考文献/References

[1]D'AGATI V D, KASKEL F J, FALK R J. Focal segmental glomerulosclerosis[J]. N Engl J Med,2011,365(25):2398-2411.
[2] XIE J,CHEN N. Primary glomerulonephritis in mainland China:an overview[J]. Contrib Nephrol,2013,181:1-11.
[3] 潘玲,黄尤,廖蕴华. 原发性局灶节段性肾小球硬化症152例临床病理特征分析[J]. 山东医药,2013,53(9):82-84.
[4] 杨利. 任继学教授对肾小球肾炎的中医理论见解[J]. 广州中医药大学学报,2003,20(1):79-81.
[5] 王永钧. 慢性原发性肾小球疾病的风湿证候[J]. 中国中西医结合肾病杂志,2007,8(12):683-685.
[6] 仝君,陈楠. 原发性局灶节段性肾小球硬化的转录组学研究[J]. 肾脏病与透析肾移植杂志,2014(4):360-367.
[7] 王海燕. 肾脏病学[M]. 北京:人民卫生出版社,2008:1043-1049.
[8] WALDMAN M,CREW R J,VALERI A,et al. Adult minimal-change disease: clinical characteristics, treatment,and outcomes[J]. Clin J Am Soc Nephrol,2007,2(3):445-453.
[9] 王缨,汪国平,张莉,等. 以肾病综合征为表现的IgA肾病67例临床与病理分析[J]. 广西医科大学学报,2013,30(1):145-147.
[10] 朱建友. IgA肾病不同年龄发作186例临床病理分析[J]. 中外医疗,2012,31(10):168.
[11] 余月娟. 中西医结合治疗慢性肾炎肾功能衰竭42例[J]. 中医研究,2006,19(3):36-38.
[12] 苟中富,王建新,刘思美,等. 加味小柴胡汤对慢性肾小球肾炎患者肾功能、尿蛋白、免疫功能的影响[J]. 检验医学与临床,2017,14(16):2448-2450.
[13] 沈庆法. 中医临床肾脏病学[M]. 上海:上海科学技术文献出版社,1997:147-191.
[14] 梁家华,姜晨光,江晓涛,等. 参芪地黄汤加减治疗慢性肾小球肾炎的Meta分析及试验序贯分析[J]. 中国药房,2018,29(12):1697-1701.
[15] 王永钧,鲁盈. 原发性肾病综合征的诊断、辨证分型及疗效评定(试行方案)[J]. 上海中医药杂志,2006,40(10):51-52.
[16] 王永钧,陈洪宇. 益肾消癥为主中西医结合治疗局灶节段性肾小球硬化[J]. 浙江中医学院学报,2002,26(1):19-21.
[17] 郭慧静,赵刚. 脾肾气虚兼湿浊血瘀型慢性肾功能衰竭危险因素回顾性分析[J]. 实用中医内科杂志,2016,30(4):1-3.
[18] DESCAMPS-LATSCHA B,WITKO-SARSAT V,NGUYEN-KHOA T, et al. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers[J]. Kidney Int,2004,66(4):1606-1612.
[19] 李先法,朱彩凤,朱斌,等. 原发性局灶节段性肾小球硬化伴IgM沉积患者的临床特征及预后分析[J]. 中华肾脏病杂志,2013,29(10):737-742.
[20] 邹丽红,黄明慧. 慢性肾炎血尿的中医药治疗[J]. 长春中医药大学学报,2015,31(1):77-79.
[21] 俞夏莉,宋欣伟,鲁盈. IgA肾病风湿证与活动性病变相关性的临床研究[J]. 浙江中医杂志,2016,51(2):84-85.
[22] 邱杰山,俞东容. 风湿扰肾证探析[J]. 中医杂志,2016, 57(7):622-624
[23] 陈洪宇,马红珍,傅晓骏,等. IgA肾病从风湿证论治的前瞻性、多中心、随机双盲对照临床研究[J]. 中华中医药杂志,2018,33(3):1184-1188.

备注/Memo

备注/Memo:
收稿日期: 2018 - 09- 12
* 基金项目: 杭州市科技发展计划项目(20160533B59;20110733Q17);浙江省朱彩凤名老中医传承工作室研究项目 (GZS2017013);浙江省卫生厅项目(2013KYA167);杭州市卫生局项目(2013A50)
第一作者简介: 李先法(1986-),男,博士,住院医师,研究方向:中医药防治肾脏病。
△通信作者: 朱彩凤,E-mail:zhcaifeng@126.com
更新日期/Last Update: 2019-06-25